Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

New NPC Report on Comparative Effectiveness Research

Research

Advances in medical research create the potential for better health outcomes, improved treatment and even prevention of once-fatal diseases and, with these improvements, a more cost-effective healthcare system.  How we use research is the key to achieving a healthier society. That’s what makes the new publication by the National Pharmaceutical Council (NPC), “2014 Comparative Effectiveness Research and the Environment for Health Care Decision-Making” so valuable.  This is the fourth year that NPC has conducted a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

New Legislation Would Stimulate Investment in Innovation

cells115x76

Today, the Coalition of Small Business Innovators (CSBI) applauds Reps. Jim Gerlach (R-PA), Richard Neal (D-MA), Mike Kelly (R-PA), and Ron Kind (D-WI) for introducing H.R. 4855, the Partnerships to Advance Revolutionary Technology and Novel Entrepreneurial Research (PARTNER) Act.  This bill would support early-stage research by incentivizing investment in R&D-focused small businesses. The PARTNER Act would allow companies to partner with their investors on a specific research project or pipeline.  Only start-up and small companies Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Video: Emerging Company CEOs Praise JOBS Act

medical_research

Passed in 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to capital formation more attainable for small biotechnology companies, clearing the way for American innovation and ingenuity by removing bureaucratic hurdles and red tape to speed cures and medical breakthroughs to patients. In this short video, leading BIO Board Members and biotech company CEOs share the reasons why they feel the JOBS Act is critically important for today’s biotech industry. The JOBS Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , ,

San Francisco Business Times: Two JOBS Acts are better than one

scientist-eyedropper

Today, the San Francisco Business Times published an op-ed by OncoMed President and CEO Paul Hastings lauding the Jumpstart Our Business Startups Act (JOBS) Act for giving emerging biotech companies a much-needed boost. As Hastings points out, 80-plus companies will have gone public in the last two years with the help of the JOBS Act. As the biotech industry gathers in San Diego next month for the 2014 BIO International Convention, several CEOs in attendance will no Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

SBIR Funds Speed the Delivery of Breakthrough Treatments and Cures

scientists115x76

Today, BIO’s Executive Vice President of Emerging Companies Cartier Esham presented testimony to the U.S. House of Representatives Committee on Small Business regarding oversight of the Small Business Innovation Research and Small Business Technology Transfer Programs (SBIR/STTR). Dr. Esham emphasized that SBIR plays a critical role in supporting small biotech companies and funding their early-stage research as they navigate the “valley of death,” a critical time when the scientific concepts have shown promise but the Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,